BMJ 2003;327 (29 November), doi:10.1136/bmj.327.7426.0-b
Balancing aspirin and statins for heart disease prevention
Aspirin and low cost antihypertensives are more cost effective than statins for preventing coronary heart disease. From his incremental cost effectiveness analysis of preventing ischaemic heart disease Marshall (p 1264) found that treating moderate risk patients with aspirin is more cost effective than treating high risk patients with statins. Cost effectiveness rankings obtained from incremental cost effectiveness analyses can be used when preparing clinical guidelines.
|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Coronary heart disease prevention: insights from modelling incremental cost effectiveness
- Tom Marshall
BMJ 2003 327: 1264.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
